Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 64,700 shares at $77.08 ($5.0M) on 2019-03-01, disclosed to the SEC on 2019-03-05.
Open-market sale of $5.0M GHDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.08 | 17,578 | $1.4M | 27.2% |
| 2 | $77.08 | 17,578 | $1.4M | 27.2% |
| 3 | $77.54 | 7,322 | $568K | 11.4% |
| 4 | $77.54 | 7,322 | $568K | 11.4% |
| 5 | $78.35 | 100 | $8K | 0.2% |
| 6 | $74.76 | 1,918 |
| $143K |
| 2.9% |
| 7 | $74.76 | 1,918 | $143K | 2.9% |
| 8 | $75.76 | 2,356 | $178K | 3.6% |
| 9 | $75.76 | 2,356 | $178K | 3.6% |
| 10 | $76.59 | 3,026 | $232K | 4.7% |
| 11 | $76.59 | 3,026 | $232K | 4.7% |
| 12 | $77.82 | 200 | $16K | 0.3% |
| Total | $76.91 avg | 64,700 | $5.0M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |